Showing 1 - 2 results of 2 for search 'Pinto A', query time: 0.01s
Refine Results
-
1
-
2
A Cost-Effectiveness Analysis of Mosunetuzumab vs Tisagenlecleucel for Treatment of Third- or Higher-Line (3L+) Relapsed or Refractory (R/R) Follicular Lymphoma (FL) in Italy by Luminari S, Pinto A, Puccini B, D’Arpino A, Omodeo Salè E, Bellone M, Pradelli L, Sabinot A
Published 2025-04-01Get full text
Article